Balyasny Asset Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,562
| Closed | -$149K | – | 2522 |
|
|
2024
Q4 | $149K | Buy |
+15,562
| New | +$149K | ﹤0.01% | 1778 |
|
|
2024
Q2 | – | Sell |
-56,837
| Closed | -$181K | – | 2522 |
|
|
2024
Q1 | $181K | Buy |
+56,837
| New | +$181K | ﹤0.01% | 1811 |
|
|
2023
Q2 | – | Sell |
-15,592
| Closed | -$48K | – | 2424 |
|
|
2023
Q1 | $48K | Sell |
15,592
-11,059
| -41% | -$34.1K | ﹤0.01% | 1954 |
|
|
2022
Q4 | $141K | Buy |
+26,651
| New | +$141K | ﹤0.01% | 1762 |
|
|
2021
Q3 | – | Sell |
-80,202
| Closed | -$804K | – | 2168 |
|
|
2021
Q2 | $804K | Buy |
+80,202
| New | +$804K | ﹤0.01% | 1184 |
|